Surgical method for implantable head mounted neurostimulation system for head pain
First Claim
1. A method for treating patients with migraine headaches, comprising the steps of:
- subcutaneously implanting at least one neurostimulator control system through an incision in the cranial region, which neurostimulator control system includes a main body disposed proximate the incision having a processor disposed therein and an interface interfacing to a first, second, and third lead of at least three integrated stimulating leads, and each of the at least three integrated stimulating leads having;
a proximal end connected to the interface, andan array of electrodes disposed along the length of the integrated stimulating lead proximate a distal end thereof and interfaced through internal wires to the processor through the interface;
extending the distal end of the first lead subcutaneously from the neurostimulator control system to the frontal cranial region so that at least one of the electrodes of the first integrated stimulating lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one supraorbital nerve;
extending the distal end of the second integrated stimulating lead subcutaneously from the neurostimulator control system to the infraorbital cranial region so that at least one of the electrodes of the second lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one infraorbital nerve;
extending the distal end of the third integrated stimulating lead subcutaneously from the neurostimulator control system to the occipital cranial region so that at least one of the electrodes of the third lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one occipital nerve; and
applying, after the extension of the first, second, and third integrated stimulating leads, at least one stimulating signal by the processor in the main body through the internal wires in the at least three integrated stimulating leads to the electrodes proximate the at least three nerves, thereby at least in part alleviating pain associated with migraine headaches.
3 Assignments
0 Petitions
Accused Products
Abstract
A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
-
Citations
20 Claims
-
1. A method for treating patients with migraine headaches, comprising the steps of:
-
subcutaneously implanting at least one neurostimulator control system through an incision in the cranial region, which neurostimulator control system includes a main body disposed proximate the incision having a processor disposed therein and an interface interfacing to a first, second, and third lead of at least three integrated stimulating leads, and each of the at least three integrated stimulating leads having; a proximal end connected to the interface, and an array of electrodes disposed along the length of the integrated stimulating lead proximate a distal end thereof and interfaced through internal wires to the processor through the interface; extending the distal end of the first lead subcutaneously from the neurostimulator control system to the frontal cranial region so that at least one of the electrodes of the first integrated stimulating lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one supraorbital nerve; extending the distal end of the second integrated stimulating lead subcutaneously from the neurostimulator control system to the infraorbital cranial region so that at least one of the electrodes of the second lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one infraorbital nerve; extending the distal end of the third integrated stimulating lead subcutaneously from the neurostimulator control system to the occipital cranial region so that at least one of the electrodes of the third lead is proximate and over at least one nerve selected from at least one of the body, branches, and roots of at least one occipital nerve; and applying, after the extension of the first, second, and third integrated stimulating leads, at least one stimulating signal by the processor in the main body through the internal wires in the at least three integrated stimulating leads to the electrodes proximate the at least three nerves, thereby at least in part alleviating pain associated with migraine headaches. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method for subcutaneously treating pain in a patient, comprising the steps of:
providing a neurostimulator with an implantable pulse generator (IPG) body and at least a primary integral lead, a secondary integral lead, and a tertiary integral lead, each lead with electrodes disposed thereon; opening a primary incision to expose the subcutaneous region below the dermis in a selected portion of the body; opening a pocket for the IPG through the primary incision; inserting the primary integral lead through the primary incision and routing it subcutaneously to a first desired nerve region along a first desired path; inserting the secondary integral lead through the primary incision and routing it subcutaneously to a second desired nerve region different than the first desired nerve region along a second desired path; inserting the tertiary integral lead through the primary incision and routing it subcutaneously to a third desired nerve region different than the first and second desired nerve regions along a third desired path; disposing the IPG in the pocket through the primary incision; closing the primary incision; and activating the IPG and the electrodes to provide localized stimulation to the desired nerve regions and at least one of the nerves associated with each of the desired nerve regions to achieve a desired pain reduction response from the patient. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
Specification